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Abstract The angiotensin AT2 receptor has been implicated in
both regeneration and apoptosis. To further investigate the
molecular mechanisms leading to AT2 receptor-induced pro-
grammed cell death in PC12W cells we studied the effects of
angiotensin II (ANG II) on ceramide levels by HPTLC analysis.
We could demonstrate that ANG II time- (1^10 h) and dose-
dependently (1038^5U1036 M) increased ceramide levels by
maximally 175% but did not affect sphingomyelin degradation.
The ANG II effects were mediated by AT2 receptors since they
were completely abolished by co-incubation with the AT2
receptor antagonist, PD123177 (1035 M), but not by the AT1
receptor antagonist, losartan (1035 M). These data suggest a
novel signal transduction pathway to the AT2 receptor leading to
apoptosis in neuronal cells.
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1. Introduction
The octapeptide angiotensin II (ANG II) inhibits, via its
AT2 receptor, cell growth [1^5] and promotes cell di¡erentia-
tion [2,6]. The AT2 receptor-induced neurite extension in
PC12W and NG108-15 cells is accompanied by di¡erential
regulation of several cytoskeletal proteins [6^8].
AT2 receptors are highly expressed during the process of
ontogenesis [9^11] in several tissues including the brain [12]
but also after myocardial infarction [13] and axotomy of sci-
atic nerves [14]. We have recently demonstrated that these
receptors can promote axonal regeneration of retinal ganglion
cells in vitro and in vivo [15], providing the ¢rst direct evi-
dence for a role of AT2 receptors in neuroregenerative proc-
esses.
Under di¡erent experimental conditions, however, AT2 re-
ceptor stimulation can also lead to apoptosis as has been
shown, among others, in PC12W [16] and rat ovarian gran-
ulosa cells [17]. This AT2 receptor-mediated apoptotic cell
death is accompanied by activation of mitogen-activated pro-
tein kinase phosphatase-1 (MKP-1) and the subsequent de-
phosphorylation of Bcl-2 [18]. In human umbilical vein endo-
thelial cells (HUVECs), AT2 receptor stimulation leads to
activation of caspase-3 (CPP-32) resulting in apoptosis [19].
The ubiquitous second messenger ceramide, one of the most
hydrophobic molecules in mammalian cells, has been impli-
cated as an important mediator of programmed cell death
[20]. Ceramide can either be synthesized de novo by conden-
sation of serine and palmitoyl-CoA [21] or be generated by
sphingomyelinases (SMases) hydrolyzing sphingomyelin [22].
Ceramides, which play a role in cellular di¡erentiation, pro-
liferation and also apoptosis in a variety of cell types [23],
have already been shown to induce apoptosis in PC12W cells
[24].
To test the hypothesis that the AT2 receptor-mediated sig-
nal transduction leading to apoptotic cell death involves the
generation of ceramides, we studied the e¡ects of ANG II on
ceramide levels in PC12W cells. Our results showing an AT2
receptor-mediated time- and dose-dependent increase in C16/
C18 ceramide levels after ANG II stimulation further eluci-
date the signal transduction pathway of AT2 receptors leading
to programmed cell death.
2. Materials and methods
2.1. Materials
Antibiotics and Dulbecco’s modi¢ed Eagle’s medium were pur-
chased from Gibco BRL (Eggenstein, Germany). Fetal calf serum
was obtained from Bio Whittaker Bioproducts (Walkersville, MD,
USA) and horse serum was supplied by Bioconcept GmbH (Umkirch,
Germany). Collagen A was purchased from Biochrom (Berlin, Ger-
many). ANG II was obtained from Bachem (Bubendorf, Switzerland)
and sphingomyelin was supplied by Sigma (Deisenhofen, Germany).
HPTLC plates were purchased from Merck (Darmstadt, Germany)
and the in situ cell death detection kit was obtained from Boehringer
Mannheim (Mannheim, Germany). Losartan was a generous gift from
Dr. R. Smith, DuPont Merck Pharmaceutical Company (Wilmington,
DE, USA), and PD123177 was generously provided by Dr. D. Taylor,
Parke Davis Pharmaceutical Research (Ann Arbor, MI, USA). Syn-
thetic ceramide (N-palmitoylsphinganine) was a generous gift from
Dr. Bernardo (Kiel, Germany) and was synthesized as described
[25]. All other reagents used were of the highest commercially avail-
able grade.
2.2. Cell culture
PC12W cells, a substrain isolated from a rat adrenal chroma⁄n cell
tumor, were maintained in Dulbecco’s modi¢ed Eagle’s medium sup-
plemented with 5% fetal calf serum, 10% horse serum and penicillin/
streptomycin (100 U/100 Wg/ml). Cells were exclusively used from
passages 9^18 and were grown at 37‡C in a humidi¢ed atmosphere
of 95% air/5% CO2. In previous studies, these cells have been dem-
onstrated to express predominantly AT2 receptors [2]. However, since
some AT1 receptor binding can be seen at higher passages, the AT1
receptor antagonist, losartan, was used in the present study to exclude
any e¡ects mediated by AT1 receptors.
In order to examine AT2 receptor-mediated e¡ects on ceramide
generation, PC12W cells (105, 2.5U105, 5U105, 106, 5U106 cells/
cm2) were ¢rst grown on collagen A-precoated culture dishes in Dul-
becco’s modi¢ed Eagle’s medium for 4 subsequent days containing 5%
fetal calf serum, 10% horse serum, penicillin/streptomycin (100 U/
100 Wg/ml) and 10 ng/ml nerve growth factor (NGF). Being cultivated
this way, the cells, which initially do not require NGF for survival,
di¡erentiate and become dependent on NGF.
Following this procedure, cells were cultured in serum-free Dulbec-
co’s modi¢ed Eagle’s medium containing penicillin/streptomycin
(100U/100 Wg/ml) and a small amount of NGF (1 ng/ml) to prevent
the onset of apoptosis.
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To determine ANG II e¡ects, cells were stimulated with ANG II
(1038^5U1036 M) for 1^10 h. In further experiments, cells were addi-
tionally treated with the AT1 receptor antagonist, losartan (1035 M)
or the AT2 receptor antagonist, PD123177 (1035 M). Vehicle-treated
cells served as negative controls.
2.3. E¡ects of ANG II on apoptosis in PC12W cells (in situ cell death
detection kit)
To detect apoptotic cell death in PC12W cells, an in situ cell death
detection kit was used according to the manufacturer’s recommenda-
tions. Brie£y, PC12W cells were cultured as described above and
treated for 48 h with ANG II (1037 M) in the presence or absence
of the respective receptor antagonists (1035 M). The air-dried cells
were ¢xed with paraformaldehyde solution (4% in PBS, pH 7.4) for
30 min at room temperature. Cells were incubated for 30 min with
blocking solution (0.3% H2O2 in methanol) followed by incubation in
permeabilization solution for 2 min on ice (0.1% Triton X-100 in 0.1%
sodium citrate). PC12W cells were rinsed with PBS and TUNEL re-
action mixture was added. After incubation in a humidi¢ed chamber
(60 min at 37‡C) converter POD was added for 30 min at 37‡C.
Finally, cells were incubated with DAB substrate solution, rinsed
and analyzed under a light microscope.
2.4. Extraction and separation of neutral lipids
After treatment, PC12W cells were harvested, centrifuged (for 5 min
at 1000Ug, 4‡C) and cell pellets were stored at 370‡C until lipid
extraction was performed as previously described [26]. Brie£y, the
samples were resuspended in methanol (1 ml), transferred to glass
tubes containing water (1 ml) and methanol (1.5 ml) and sonicated
for 5 min. After addition of chloroform (1.25 ml), the samples were
centrifuged for 10 min at 6000Ug and the supernatants were saved in
new glass vials. The pellets were resuspended in a mixture of water
(1 ml), methanol (2.5 ml) and chloroform (1.25 ml) and were centri-
fuged for phase separation (5 min, 4000Ug). Water (2.5 ml) and
chloroform (2.5 ml) were added to the combined supernatants. After
centrifugation (5 min, 4000Ug) the lower organic phase was trans-
ferred to new vials and the procedure was repeated once. The com-
bined chloroform phases were dried down under nitrogen and the
pellets were dissolved in chloroform/methanol (ratio 9:1).
2.5. Thin-layer chromatography (HPTLC) for ceramide detection and
charring densitometry
After pre-running of HPTLC plates in a solvent system composed
of chloroform/methanol (ratio 1:1), the resuspended samples were
spotted onto the completely dried plates. The TLC plates were placed
in an equilibrated chamber (solvent system for ceramides: dichloro-
methane/methanol/acetic glacial acid (100:2:5); for sphingomyelin:
chloroform/methanol/acetic glacial acid/water (100:60:20:5)) and the
plates were allowed to develop at room temperature.
The TLC separation was followed by visualization and quanti¢ca-
tion of phospholipids by charring of the plates with cupric reagent
[26]. The plates were dried for 10 min at 180‡C, cooled down to room
temperature and exposed to a solution of 10% copper(II) sulfate in 8%
aqueous phosphoric acid for 15 s. After drying (2 min, 110‡C), char-
ring was performed at 175‡C for approx. 10 min. For quanti¢cation,
the charred TLC plates were scanned by 2D laser scanner densitom-
etry (Molecular Dynamics personal densitometer).
2.6. Statistics
Statistical comparison of data was performed using one-way anal-
ysis of variance (ANOVA) followed by an appropriate post-hoc test
(Bonferroni). A probability of P6 0.05 or less was considered signi¢-
cant. Further details of statistical analysis are given in the legends to
the ¢gures.
3. Results
3.1. AT2 receptor-mediated induction of apoptosis
To establish our experimental model, the e¡ects of ANG II
on apoptotic cell death in PC12W cells (106 cells/cm2) were
investigated by TUNEL staining using the in situ cell death
detection kit. PC12W cells cultivated in the presence of 1 ng/ml
NGF served as negative control and did not undergo
apoptosis (Fig. 1a). Treatment of these cells with ANG II
(1037 M) induced apoptosis as depicted in Fig. 1b. The
ANG II-induced e¡ects were mediated by AT2 receptors since
they were completely suppressed by pretreatment with the
AT2 receptor antagonist, PD123177 (1035 M), but not af-
fected by the AT1 receptor antagonist, losartan (1035 M)
(data not shown).
3.2. Correlation of ceramide levels and PC12W cell density
PC12W cells were plated at di¡erent cell densities (105,
2.5U105, 5U105, 106, 5U106 cells/cm2) in order to determine
the optimal experimental cell number. An increase in ceramide
levels was detected in parallel with an increase in cell density
(data not shown).
Since saturation was to be avoided to allow detection of
alterations in ceramide levels, a cell density of 106 cells/cm2
was chosen for the investigation.
3.3. Time-dependent ANG II e¡ects on ceramide levels
To determine the time dependence of ANG II e¡ects on
ceramide levels, PC12W cells were stimulated with ANG II
(5U1036 M) for 1, 2, 4, 6, 8 and 10 h. The basal ceramide
content was 4.2 nmol/1036 cells/cm2. Compared to untreated
cells, signi¢cantly enhanced ceramide levels were observed
after 8 and 10 h (175% and 188%, respectively) whereas no
changes could be detected after 1^6 h (Fig. 2).
According to these observations, all subsequent experiments
were performed based on an 8 h treatment with ANG II
in the absence or presence of the respective receptor antago-
nists.
3.4. Dose-dependent ANG II e¡ects on ceramide levels
PC12W cells were stimulated for 8 h with increasing ANG
II concentrations (1038^5U1036 M) resulting in a dose-de-
pendent increase of ceramide levels (Fig. 3). Signi¢cant
ANG II e¡ects were observed starting with a concentration
of 1037 M (120%). Co-incubation with ANG II at higher
concentrations (1036 M and 5U1036 M) resulted in further
increases of ceramide (142% and 175%, respectively).
Based on these studies, the following experiments were
carried out for 8 h with an ANG II concentration of 1036 M.
3.5. Determination of the involved angiotensin receptor subtype
In lower passages, PC12W cells have previously been dem-
onstrated to express AT2 but not AT1 receptors. To con¢rm
that the observed ANG II e¡ects were AT2 receptor-mediated,
the cells were pretreated with either the selective AT1 receptor
antagonist, losartan (1035 M), or the selective AT2 receptor
antagonist, PD123177 (1035 M).
As depicted in Fig. 4, the ANG II-induced (1036 M) ceram-
ide generation (142%) was completely abolished by co-incu-
bation with the selective AT2 receptor antagonist PD123177
in the absence (109%) or presence of the AT1 receptor antag-
onist, losartan (102%). The AT1 receptor antagonist, losartan,
also did not a¡ect these ANG II e¡ects by itself (152.5%)
indicating that the ANG II-induced ceramide generation is
due to an AT2 receptor activation.
3.6. Sphingomyelin determination
To investigate whether the observed generation of ceramide
is due to degradation of sphingomyelin by means of sphingo-
myelinases or de novo synthesis, PC12W cells were harvested
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after treatment and divided into two fractions. This procedure
allowed the determination of both ceramides and sphingomye-
lin, from the same sample by using two di¡erent solvents for
HPTLC separation (see Section 2). The sphingomyelin con-
centration did not change after an 8 h stimulation with ANG
II at di¡erent doses (1038^5U1036 M) compared to untreated
control cells (data not shown).
4. Discussion
Previous studies have demonstrated that ANG II is capable
of inducing apoptosis via AT2 receptors. The mechanism of
action involves e.g. activation of MKP-1 and subsequent de-
phosphorylation of Bcl-2 in PC12W cells [18] but also stim-
ulation of CPP-32 in HUVECs [19]. Since the second messen-
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Fig. 1. AT2 receptor stimulation induced apoptosis in PC12W cells as evidenced by internucleosomal DNA strand breaks and detected by
TUNEL staining. Whereas no apoptosis was observed in cells cultivated in the presence of NGF (1 ng/ml) (a), treatment with ANG II
(1037 M) for 48 h (b) resulted in programmed cell death. These ANG II-induced e¡ects were completely abolished by co-incubation with the
selective AT2 receptor antagonist, PD 123177 (1035 M), but not a¡ected by the AT1 receptor antagonist, losartan (1035 M).
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ger, ceramide, represents a possible activator of CPP-32 we
were prompted to investigate possible AT2 receptor-mediated
e¡ects on ceramide levels.
To con¢rm previous studies and to establish our experimen-
tal model, the apoptotic e¡ects of ANG II in PC12W cells
were investigated by TUNEL staining, and, under the condi-
tions described (see Section 2), it could be demonstrated that
AT2 receptor stimulation mediates apoptosis in these cells
(Fig. 1).
The present study now demonstrates that under identical
experimental conditions, AT2 receptor stimulation induces
generation of the lipid second messenger ceramide ascribing
a novel signal transduction pathway to these receptors. The
ANG II e¡ects were dose- and time-dependent and were en-
tirely suppressed by co-incubation with the selective AT2 re-
ceptor antagonist, PD123177, but not with the AT1 receptor
antagonist, losartan. The ANG II e¡ects did not include alter-
ations in sphingomyelin levels suggesting a lack of activation
of SMases and, thus, pointing to an AT2 receptor-mediated de
novo synthesis of ceramide.
A number of observations support the view that ceramide
plays an important role in mediating apoptosis. It has for
instance been shown that environmental stresses such as UV
radiation or oxidative stress induce ceramide generation
[27,28]. Ceramide not only activates the SAPK/JNK cascade
but also acts on mitochondrial permeability leading to activa-
tion of caspases and, ¢nally, to apoptosis (for review see [23]).
Although numerous questions remain to be answered regard-
ing the precise role of ceramide in apoptotic signalling, the
¢nding of an AT2 receptor-mediated ceramide generation in
PC12W cells connects this receptor to important apoptotic
pathways which have to be elucidated in the future.
Although it was not investigated in the present study
whether ANG II leads to activation of SMases or ceramide
synthase, the time course of ceramide generation suggests an
ANG II-induced de novo synthesis. In contrast to SMases
which are activated within minutes, activation of ceramide
synthase requires hours. In addition, the lack of AT2 recep-
tor-mediated sphingomyelin degradation in PC12W cells sup-
ports a role of ceramide synthase since SMase activity in-
volves sphingomyelin breakdown. However, it should be
noted that sphingomyelin levels are high compared to ceram-
ide levels and that minor changes in the sphingomyelin con-
tent might not be detected by the assay used. Further inves-
tigations will, thus, be necessary to unambiguously answer
this question.
Taken together, we could show for the ¢rst time that the
AT2 receptor-mediated apoptosis in PC12W cells involves ce-
ramide generation, thus attributing a novel signal transduc-
tion pathway to these receptors. Future investigations have to
elucidate whether ANG II actions involve de novo synthesis
of ceramide or sphingomyelin breakdown.
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Fig. 2. Stimulation of PC12W cells with ANG II (5U1036 M)
evoked time-dependent increases of ceramide levels. Signi¢cant ef-
fects were observed after 8 and 10 h whereas no changes were de-
tected between 1 and 6 h (n = 4, mean þ S.E.M.). *P6 0.05 com-
pared to respective untreated cells.
Fig. 3. Treatment of PC12W cells with increasing ANG II concen-
trations (1038^5U1036 M) resulted in dose-dependent increases in
ceramide generation (data are from single experiments representative
of four independent experiments, mean þ S.E.M.). *P6 0.05 com-
pared to respective untreated cells.
Fig. 4. Co-stimulation of PC12W cells with ANG II (1036 M) and
the selective AT2 receptor antagonist, PD 123177 (1035 M), entirely
abolished the ANG II-induced ceramide synthesis whereas it was
not a¡ected by the AT1 receptor antagonist, losartan (1035 M)
(n = 4, mean þ S.E.M.). *P6 0.05 compared to respective untreated
cells.
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